FIELD: virology, vaccines. SUBSTANCE: invention relates to preparing live attenuated vaccine based on varicella-zoster and shingles extracellular virus. Method involves culturing monolayer cultures in medium enriched with lipid additions that ensures to increase the yield of viral plaque-forming units and viral antigen. Using standard flasks for culturing cell density achieves 500 000 cells/cm2. and use of an optimal conditions during culturing ensures to increase viral vaccine producing. Invention can be used in biotechnology and immunology. EFFECT: improved method of vaccine preparing. 12 cl, 5 dwg, 6 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
POLYNUCLEOTIDE ANTITUBERCULOSIS VACCINE | 1995 |
|
RU2186109C2 |
METHOD OF OBTAINING LIVE CULTURAL ATTENUATED VACCINE FOR THE PREVENTION OF VARICELLA | 2016 |
|
RU2637093C1 |
PAPILLOMA VIRAL VACCINES | 1995 |
|
RU2206608C2 |
STRAIN OF HUMAN EMBRYO LUNG FIBROBLAST DIPLOID CELLS USED FOR VIRUS CULTURING | 1997 |
|
RU2146289C1 |
INACTIVATED VACCINES AGAINST VARICELLA-ZOSTER VIRUS, METHODS FOR THEIR PRODUCTION AND APPLICATION | 2011 |
|
RU2633058C2 |
POLYNUCLEOTIDE VACCINE FOR PAPILLOMA VIRUS | 1995 |
|
RU2173170C2 |
VIRUS VACCINE AND METHODS FOR PRODUCTION THEREOF | 2014 |
|
RU2706693C2 |
SERUM-FREE MEDIUM FOR PRODUCTION OF AVIAN VACCINE AND ITS USE | 2020 |
|
RU2819260C2 |
RECOMBINANT VACCINE AGAINST VARICELLA ZOSTER VIRUS (VZV) | 2020 |
|
RU2772902C1 |
DNA STRUCTURE (VARIANTS), DNA-VECTOR, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, METHOD OF IMMUNE RESPONSE INDUCTION, VACCINE AND METHOD OF VACCINATION | 1994 |
|
RU2193065C2 |
Authors
Dates
1999-02-20—Published
1993-05-26—Filed